COL23A1
gene geneOn this page
Also known as DKFZp434K0621
Summary
COL23A1 (collagen type XXIII alpha 1 chain, HGNC:22990) is a protein-coding gene on chromosome 5q35.3, encoding Collagen alpha-1(XXIII) chain (Q86Y22).
COL23A1 is a member of the transmembrane collagens, a subfamily of the nonfibrillar collagens that contain a single pass hydrophobic transmembrane domain (Banyard et al., 2003 [PubMed 12644459]).
Source: NCBI Gene 91522 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 125 total
- MANE Select transcript:
NM_173465
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22990 |
| Approved symbol | COL23A1 |
| Name | collagen type XXIII alpha 1 chain |
| Location | 5q35.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434K0621 |
| Ensembl gene | ENSG00000050767 |
| Ensembl biotype | protein_coding |
| OMIM | 610043 |
| Entrez | 91522 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 4 nonsense_mediated_decay, 3 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000390654, ENST00000407622, ENST00000484750, ENST00000646779, ENST00000679888, ENST00000679896, ENST00000680268, ENST00000680889, ENST00000681261
RefSeq mRNA: 1 — MANE Select: NM_173465
NM_173465
CCDS: CCDS4436
Canonical transcript exons
ENST00000390654 — 29 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000770283 | 178239141 | 178239179 |
| ENSE00000770284 | 178242042 | 178242128 |
| ENSE00000973022 | 178249117 | 178249206 |
| ENSE00000973024 | 178247775 | 178247831 |
| ENSE00000973025 | 178247526 | 178247552 |
| ENSE00000973026 | 178246391 | 178246453 |
| ENSE00000973027 | 178246254 | 178246307 |
| ENSE00000973029 | 178242341 | 178242394 |
| ENSE00001290409 | 178256866 | 178256928 |
| ENSE00001293360 | 178250061 | 178250105 |
| ENSE00001295338 | 178248192 | 178248254 |
| ENSE00001300755 | 178262217 | 178262252 |
| ENSE00001307117 | 178267307 | 178267333 |
| ENSE00001309173 | 178306875 | 178306919 |
| ENSE00001323944 | 178257523 | 178257567 |
| ENSE00001325296 | 178263208 | 178263324 |
| ENSE00001325792 | 178256353 | 178256397 |
| ENSE00001356640 | 178252544 | 178252597 |
| ENSE00001356641 | 178254949 | 178255026 |
| ENSE00001356695 | 178589904 | 178590393 |
| ENSE00001399827 | 178270337 | 178270363 |
| ENSE00001404070 | 178261722 | 178261748 |
| ENSE00001407776 | 178268730 | 178268756 |
| ENSE00001419363 | 178245942 | 178245968 |
| ENSE00001424779 | 178288324 | 178288350 |
| ENSE00001425372 | 178259721 | 178259747 |
| ENSE00001508549 | 178237618 | 178238700 |
| ENSE00002483769 | 178290362 | 178290369 |
| ENSE00003483384 | 178560682 | 178560748 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 95.52.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8376 / max 125.4838, expressed in 404 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 65176 | 1.3070 | 351 |
| 65175 | 0.4860 | 170 |
| 65174 | 0.0447 | 19 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of thyroid gland | UBERON:0001119 | 95.52 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.06 | gold quality |
| thyroid gland | UBERON:0002046 | 94.89 | gold quality |
| apex of heart | UBERON:0002098 | 86.76 | gold quality |
| heart left ventricle | UBERON:0002084 | 86.01 | gold quality |
| cardiac ventricle | UBERON:0002082 | 85.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.40 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.91 | gold quality |
| ileal mucosa | UBERON:0000331 | 79.04 | gold quality |
| heart | UBERON:0000948 | 78.02 | gold quality |
| skin of abdomen | UBERON:0001416 | 76.35 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.12 | gold quality |
| sural nerve | UBERON:0015488 | 76.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 75.39 | gold quality |
| skin of leg | UBERON:0001511 | 75.00 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 74.76 | gold quality |
| cardiac atrium | UBERON:0002081 | 74.72 | gold quality |
| tibialis anterior | UBERON:0001385 | 74.42 | silver quality |
| seminal vesicle | UBERON:0000998 | 74.06 | gold quality |
| zone of skin | UBERON:0000014 | 73.69 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.68 | gold quality |
| pancreatic ductal cell | CL:0002079 | 73.63 | silver quality |
| tibial nerve | UBERON:0001323 | 73.21 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.88 | gold quality |
| right lung | UBERON:0002167 | 72.86 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.45 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 72.02 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.87 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 71.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.37 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
64 targeting COL23A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-3934-5P | 99.67 | 64.04 | 846 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
Literature-anchored findings (GeneRIF, showing 5)
- identification and cloning; a new member of the transmembrane collagen family, showing structural homology with the transmembrane collagens XIII and XXV (PMID:12644459)
- analysis of collagen XXIII mRNA and protein (PMID:16728390)
- newly synthesized collagen XXIII either is cleaved inside the Golgi/trans-Golgi network or reaches the cell surface, where it becomes protected from processing by being localized in lipid rafts. (PMID:17627939)
- High COL23A1 expression is associated with recurrent non-small cell lung cancer. (PMID:20447926)
- data suggest that extracellular membrane-bound CAIV, but not cytosolic CAII, augments transport activity of MCT2 in a non-catalytic manner, possibly by facilitating a proton pathway other than His-88 (PMID:21652699)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | col7a1l | ENSDARG00000069692 |
| danio_rerio | si:dkey-117n7.4 | ENSDARG00000092064 |
| ENSDARG00000105274 | ||
| mus_musculus | Col23a1 | ENSMUSG00000063564 |
| rattus_norvegicus | Col23a1 | ENSRNOG00000003349 |
Paralogs (37): COL9A2 (ENSG00000049089), COL11A1 (ENSG00000060718), COL17A1 (ENSG00000065618), COL5A3 (ENSG00000080573), COL4A4 (ENSG00000081052), COL16A1 (ENSG00000084636), COL9A3 (ENSG00000092758), COL20A1 (ENSG00000101203), COL1A1 (ENSG00000108821), COL9A1 (ENSG00000112280), COL7A1 (ENSG00000114270), COL21A1 (ENSG00000124749), COL5A1 (ENSG00000130635), COL4A2 (ENSG00000134871), COL2A1 (ENSG00000139219), COL6A1 (ENSG00000142156), COL6A2 (ENSG00000142173), EDA (ENSG00000158813), COL26A1 (ENSG00000160963), COL1A2 (ENSG00000164692), COL3A1 (ENSG00000168542), COL4A3 (ENSG00000169031), COL22A1 (ENSG00000169436), COL24A1 (ENSG00000171502), COL18A1 (ENSG00000182871), EMID1 (ENSG00000186998), COL4A1 (ENSG00000187498), COL4A5 (ENSG00000188153), COL25A1 (ENSG00000188517), COL27A1 (ENSG00000196739), COL13A1 (ENSG00000197467), COL4A6 (ENSG00000197565), COL11A2 (ENSG00000204248), COL5A2 (ENSG00000204262), COL15A1 (ENSG00000204291), COLQ (ENSG00000206561), COL28A1 (ENSG00000215018)
Protein
Protein identifiers
Collagen alpha-1(XXIII) chain — Q86Y22 (reviewed: Q86Y22)
All UniProt accessions (5): A0A0A0MSD3, A0A2R8Y887, A0A7P0T8B8, Q86Y22, L8EAS4
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Homotrimer.
Subcellular location. Cell membrane.
Post-translational modifications. Undergoes proteolytic cleavage by furin protease to yield a 60 kDa soluble form that forms a homotrimer and exhibits a low affinity interaction with heparin.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86Y22-1 | 1 | yes |
| Q86Y22-2 | 2 |
RefSeq proteins (1): NP_775736* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008160 | Collagen | Repeat |
| IPR050938 | Collagen_Structural_Proteins | Family |
Pfam: PF01391
UniProt features (27 total): compositionally biased region 9, splice variant 5, domain 5, region of interest 3, topological domain 2, chain 1, transmembrane region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86Y22-F1 | 59.01 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1442490 | Collagen degradation |
| R-HSA-1650814 | Collagen biosynthesis and modifying enzymes |
| R-HSA-216083 | Integrin cell surface interactions |
| R-HSA-8948216 | Collagen chain trimerization |
MSigDB gene sets: 82 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_UP, GOCC_COLLAGEN_TRIMER, GOCC_CELL_SURFACE, SRF_Q5_01, AAACCAC_MIR140, GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP, GOMF_GLYCOSAMINOGLYCAN_BINDING, OCT1_B, CCCNNGGGAR_OLF1_01, GOMF_HEPARIN_BINDING, REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, GOMF_SULFUR_COMPOUND_BINDING
GO Biological Process (0):
GO Molecular Function (4): heparin binding (GO:0008201), extracellular matrix structural constituent conferring tensile strength (GO:0030020), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (7): collagen trimer (GO:0005581), obsolete extracellular space (GO:0005615), endoplasmic reticulum lumen (GO:0005788), plasma membrane (GO:0005886), cell surface (GO:0009986), extracellular matrix (GO:0031012), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Degradation of the extracellular matrix | 1 |
| Collagen formation | 1 |
| Extracellular matrix organization | 1 |
| Collagen biosynthesis and modifying enzymes | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| glycosaminoglycan binding | 1 |
| sulfur compound binding | 1 |
| extracellular matrix structural constituent | 1 |
| protein binding | 1 |
| binding | 1 |
| protein-containing complex | 1 |
| endoplasmic reticulum | 1 |
| intracellular organelle lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
| external encapsulating structure | 1 |
Protein interactions and networks
STRING
1050 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COL23A1 | FURIN | P09958 | 568 |
| COL23A1 | C2CD4D | B7Z1M9 | 480 |
| COL23A1 | MMP9 | P14780 | 451 |
| COL23A1 | COL26A1 | Q96A83 | 438 |
| COL23A1 | SLC16A2 | P36021 | 428 |
| COL23A1 | PHYKPL | Q8IUZ5 | 404 |
| COL23A1 | TMEM184C | Q9NVA4 | 400 |
| COL23A1 | SPATA17 | Q96L03 | 378 |
| COL23A1 | CPLX3 | Q8WVH0 | 337 |
| COL23A1 | COL8A1 | P27658 | 332 |
| COL23A1 | PCOLCE2 | Q9UKZ9 | 332 |
| COL23A1 | COL25A1 | Q9BXS0 | 318 |
| COL23A1 | LAMB3 | Q13751 | 311 |
| COL23A1 | ANKS1B | Q7Z6G8 | 302 |
| COL23A1 | ANKFY1 | Q9P2R3 | 300 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EXOSC8 | COL23A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COL23A1 | EXOSC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COL23A1 | RPL10A | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL23A1 | SYNE2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL23A1 | H4C16 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL23A1 | H1-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL23A1 | LMNA | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL23A1 | CFTR | psi-mi:“MI:0915”(physical association) | 0.370 |
| COL23A1 | PLOD2 | psi-mi:“MI:0914”(association) | 0.350 |
| LSM8 | COL23A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): COL23A1 (Two-hybrid), COL23A1 (Affinity Capture-RNA), COL23A1 (Proximity Label-MS), SYNE2 (Proximity Label-MS), COL23A1 (Proximity Label-MS), COL23A1 (Proximity Label-MS), COL23A1 (Proximity Label-MS), COL23A1 (Two-hybrid), PLOD2 (Affinity Capture-MS), PLOD1 (Affinity Capture-MS), COLGALT1 (Affinity Capture-MS), PLOD3 (Affinity Capture-MS), COL23A1 (PCA), COL23A1 (Co-fractionation), COL23A1 (Co-fractionation)
ESM2 similar proteins: C0HLH0, C0HLH4, C0HLI6, C0HLN2, P02460, P02462, P02463, P05997, P08120, P08122, P08125, P08572, P12106, P12107, P12108, P13942, P20849, P20850, P20909, P23206, P25318, P27393, P29400, P30754, P32017, P70560, Q01955, Q03692, Q05306, Q05722, Q07643, Q0VF58, Q14031, Q14050, Q14055, Q14993, Q28083, Q28247, Q32S24, Q3U962
Diamond homologs: Q810Y4, Q86Y22, Q8K4G2, Q99MQ5, Q9BXS0, Q9R1N9, Q5TAT6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
125 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 93 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
8041 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:178239127:T:TA | donor_gain | 1.0000 |
| 5:178239128:C:A | donor_gain | 1.0000 |
| 5:178246389:A:AC | donor_gain | 1.0000 |
| 5:178246390:C:CC | donor_gain | 1.0000 |
| 5:178248191:CCAGG:C | donor_gain | 1.0000 |
| 5:178248199:T:A | donor_gain | 1.0000 |
| 5:178256804:C:CA | donor_gain | 1.0000 |
| 5:178261718:TCA:T | donor_loss | 1.0000 |
| 5:178261719:CACCT:C | donor_loss | 1.0000 |
| 5:178261750:T:A | acceptor_loss | 1.0000 |
| 5:178263202:TCTTA:T | donor_loss | 1.0000 |
| 5:178263203:CTTAC:C | donor_loss | 1.0000 |
| 5:178263204:TTACC:T | donor_loss | 1.0000 |
| 5:178263205:TA:T | donor_loss | 1.0000 |
| 5:178263206:A:AC | donor_gain | 1.0000 |
| 5:178263207:C:CC | donor_gain | 1.0000 |
| 5:178263207:CCG:C | donor_gain | 1.0000 |
| 5:178270335:A:AC | donor_gain | 1.0000 |
| 5:178270336:C:CC | donor_gain | 1.0000 |
| 5:178270336:CGGG:C | donor_gain | 1.0000 |
| 5:178238606:CCA:C | acceptor_gain | 0.9900 |
| 5:178238607:C:CT | acceptor_gain | 0.9900 |
| 5:178238607:C:T | acceptor_gain | 0.9900 |
| 5:178238608:A:AC | acceptor_gain | 0.9900 |
| 5:178238608:A:C | acceptor_gain | 0.9900 |
| 5:178238699:CA:C | acceptor_gain | 0.9900 |
| 5:178238701:C:CC | acceptor_gain | 0.9900 |
| 5:178239138:TA:T | donor_loss | 0.9900 |
| 5:178239139:ACC:A | donor_loss | 0.9900 |
| 5:178239140:CCTTA:C | donor_loss | 0.9900 |
AlphaMissense
3345 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:178242050:A:G | C525R | 0.996 |
| 5:178242049:C:G | C525S | 0.994 |
| 5:178242049:C:T | C525Y | 0.994 |
| 5:178242050:A:T | C525S | 0.994 |
| 5:178239152:A:G | C537R | 0.993 |
| 5:178239151:C:G | C537S | 0.992 |
| 5:178239152:A:T | C537S | 0.992 |
| 5:178242048:A:C | C525W | 0.992 |
| 5:178246279:C:T | G463E | 0.990 |
| 5:178263251:C:T | G199D | 0.990 |
| 5:178270362:C:T | G148E | 0.990 |
| 5:178290369:C:T | G136D | 0.990 |
| 5:178306901:C:T | G127D | 0.990 |
| 5:178239151:C:T | C537Y | 0.988 |
| 5:178242109:C:T | G505D | 0.988 |
| 5:178242393:C:T | G481D | 0.988 |
| 5:178288331:C:T | G145D | 0.988 |
| 5:178306892:C:T | G130E | 0.988 |
| 5:178246270:C:T | G466E | 0.987 |
| 5:178288340:C:T | G142E | 0.987 |
| 5:178306883:C:T | G133D | 0.987 |
| 5:178239150:G:C | C537W | 0.986 |
| 5:178263233:C:T | G205D | 0.986 |
| 5:178288349:C:T | G139E | 0.985 |
| 5:178263260:C:T | G196D | 0.984 |
| 5:178306910:C:T | G124E | 0.984 |
| 5:178242049:C:A | C525F | 0.983 |
| 5:178242101:C:G | G508R | 0.983 |
| 5:178242101:C:T | G508R | 0.983 |
| 5:178263242:C:T | G202E | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000006999 (5:178366215 C>T), RS1000010297 (5:178455080 A>C), RS1000022030 (5:178561888 G>A), RS1000031708 (5:178328348 G>A,C), RS1000041509 (5:178355224 T>C), RS1000042797 (5:178476197 G>A), RS1000044695 (5:178532717 C>T), RS1000050207 (5:178285112 G>C), RS1000062309 (5:178292672 T>C,G), RS1000070475 (5:178417822 C>T), RS1000071684 (5:178465713 C>T), RS1000074115 (5:178355371 C>G), RS1000092318 (5:178587992 A>C,G,T), RS1000138917 (5:178379061 G>A,T), RS1000150563 (5:178449892 C>T)
Disease associations
OMIM: gene MIM:610043 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_247 | Obesity-related traits | 6.000000e-06 |
| GCST001958_7 | Bulimia nervosa | 6.000000e-06 |
| GCST003465_17 | Cannabis dependence symptom count | 2.000000e-07 |
| GCST003563_10 | Presence of antiphospholipid antibodies | 3.000000e-06 |
| GCST006085_81 | Prostate cancer | 7.000000e-09 |
| GCST006499_1 | Nose length | 3.000000e-10 |
| GCST006585_2990 | Blood protein levels | 4.000000e-07 |
| GCST012320_1 | HDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder | 2.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005106 | body composition measurement |
| EFO:0008457 | cannabis dependence measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 6 |
| trichostatin A | affects cotreatment, increases expression | 3 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| Benzo(a)pyrene | increases methylation, affects methylation, decreases methylation | 2 |
| Aflatoxin B1 | increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| benzo(e)pyrene | affects methylation | 1 |
| aflatoxin B2 | affects methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Vorinostat | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects methylation | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Methapyrilene | affects methylation | 1 |
| Rotenone | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bulimia nervosa